Search





Search





Markets
/
Stocks
/
nasdaq-ngen
/

Nervgen Pharma Ord Shs

NGEN

Add to Watchlist

3.565USD

-0.145-3.91%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

287.12MMarket Cap

LossP/E TTM



Nervgen Pharma Ord Shs

3.565

-0.145-3.91%

Overview Financials Discussions Analysis Company

Overview

Financials

Discussions

Analysis

Company

You can check out the annual or quarterly balance sheets of Nervgen Pharma Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

Total equity

Cash, cash equivalents and short-term investments

--12.08M

--15.86M

- Cash and cash equivalents

--12.08M

--15.86M

Receivables

--68.26K

--64.10K

-Accounts and notes receivable

--68.26K

--58.09K

-Loans receivable

--0.00

--6.01K

Prepaid expenses

--2.71M

--419.94K

Other current assets

--0.00

--41.21K

Total current assets

--14.87M

--16.39M

Non-current assets

Goodwill and other intangible assets

--288.41K

--294.07K

Other non-current assets

--0.00

Total non-current assets

--288.41K

--294.07K

Total assets

--15.15M

--16.68M

Liabilities

Current liabilities

-Other payables

--0.00

Accrued expenses

----

--979.54K

Short-term debt and lease liabilities

--0.00

--6.01K

-Short-term lease liabilities

--0.00

--6.01K

Other current liabilities

--0.00

Total current liabilities

--11.11M

--14.18M

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Total non-current liabilities

----

--0.00

Total liabilities

--4.04M

--14.18M

Shareholders' equity

Common equity

--78.74M

--74.03M

Retained earnings

---74.69M

---71.53M

Total equity

----

--2.50M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

